Immune to Cancer: The CRI Blog
-
CRI Celebrates a Future #Immune2Cancer on June 12
On Friday, June 12, 2020, the global cancer community joined the Cancer Research Institute’s annual awareness day to amplify the lifesaving potential…
-
Recapping ASCO20: The Next Horizons in Immunotherapy
The 56th Annual ASCO Meeting highlighted advances in checkpoint immunotherapy, cell-based immunotherapies, and bispecific antibodies.
-
ASCO20 Update: Considerations for Checkpoint Inhibitors Moving Forward
Results unveiled at ASCO20 increased our understanding of checkpoint immunotherapy in a variety of cancers and circumstances.
-
ASCO20 Update: Cellular Immunotherapies, Genomics, and COVID-19
Several promising cellular immunotherapies were discussed at ASCO20, including those for solid cancers; plus updates on the cancer…
-
Investigating the Innate Immune Receptor NLRP6 with Dr. Chen Shen
CRI Fellow Dr. Chen Shen is investigating NLRP6, a receptor that can recognize bacteria or viruses and…
-
Building a Single-Cell Atlas with Dr. Ansuman Satpathy
Dr. Ansuman Satpathy is building a single-cell atlas to help us better understand why immunotherapy succeeds or…
-
An Epic Podcast Fundraiser for Cancer Research Returns for a Fourth Year
While many are adjusting to virtual fundraisers at the moment, the Epic Film Guys now have plenty…
-
Four Virtual Fundraising Ideas for Cancer Immunotherapy Month
Host your own themed event and raise money to fuel cancer immunotherapy research.

Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.